Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories


Grail spins back into Illumina for $8bn
Two weeks after filing to go public, Grail has instead accepted an $8bn acquisition offer from Illumina, which had spun off the cancer diagnostics technology developer five years ago.
WM Motor wins over investors for $1.47bn series D
Baidu, Tencent and China Minmetals-backed electric vehicle producer WM Motor has raised $1.47bn in a series D round to support R&D, marketing and sales activities.
Acesso Digital taps into $107m series B
SoftBank’s Latin America Fund and General Atlantic have co-led a $107m series B round for Acesso Digital, a facial recognition technology developer that will use the money to scale.
Playco starts funding game with $100m
Digital Garage has helped launch mobile gaming platform Playco with a $100m series A round and a valuation of more than $1bn.
Leyan locks in series C2
The Kunlun-backed customer engagement software provider has closed its series C round at about $44m, having raised a similar amount in series C1 funding four months ago.
K Wah helps Hrain close series B-plus
K Wah Group’s subsidiary has taken part in the tumour therapy and drug developer’s $29.3m round, which came a year after its $28m series B round.

News Continued

Oncocross smiles with new round
Seeq adds Cisco to series B round
Baijiayun basks in $26.3m series B
Cash Capital was among the investors for Baijiayun, a Mooc platform whose shareholders also include Xiaodu Huyu, Huatu Education and BaishanCloud.
Chime rings $485m funding bell
Chime has increased its valuation nearly tenfold in 18 months and is worth $14.5bn following a $485m series F round that included existing shareholder Access Industries.
Roche fires up $448m Inflazome acquisition
Novartis-backed Inflazome, which advances University of Queensland and Trinity College Dublin research to develop treatments for inflammation, has been bought by Roche for $448m.
Compass navigates IPO
Compass Pathways has raised more than $127m in an upsized initial public offering that provided an exit to Otsuka Pharmaceuticals.

Editor's Picks

Amwell rams its way to $742m IPO
The telehealth system provider is going public in an $742m upsized offering that will enable Philips, Allianz, Teva and Takeda to exit.
Snowflake hits public markets in $3.36bn IPO
Salesforce Ventures will invest another $250m as the data management software provider floated above its range at a valuation just short of $29bn.
Opendoor welcomes reverse merger
Lennar, SoftBank, Access Industries and Alphabet are set to score exits from the real estate transaction manager, valued at $4.8bn in the deal.
Zwift rides momentum to $450m
Amazon Alexa Fund and Specialized Bicycle Components vehicle Zone 5 Ventures helped the social exercise platform raise money at a valuation above $1bn.
test reg